Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
Cambridge, Massachusetts
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
9d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
North Carolina
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
9d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
Virginia
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
9d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
Maine
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
9d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
Rhode Island
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
9d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
D.C.
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
9d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
Florida
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
9d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
New York
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
9d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
Connecticut
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
9d
| Job Type | Full Time |
Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy
New Hampshire
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, centr...
9d
| Job Type | Full Time |